Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
LGND

Ligand

$260.52

3.01 (1.17%)

07:08
09/24/18
09/24
07:08
09/24/18
07:08
Conference/Events
Ligand management to meet with Stephens »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 06

    Nov

Wednesday
LGND

Ligand

, VKTX

Viking Therapeutics

$19.47

9.07 (87.21%)

07:13
09/19/18
09/19
07:13
09/19/18
07:13
Recommendations
Ligand, Viking Therapeutics analyst commentary at H.C. Wainwright »

Ligand price target…

LGND

Ligand

VKTX

Viking Therapeutics

$19.47

9.07 (87.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 01

    Oct

  • 06

    Nov

Tuesday
LGND

Ligand

$253.55

-1.17 (-0.46%)

, VKTX

Viking Therapeutics

$10.40

-0.18 (-1.70%)

09:36
09/18/18
09/18
09:36
09/18/18
09:36
Hot Stocks
Ligand rises after Viking's study of VK2809 hits primary goal »

Shares of Ligand…

LGND

Ligand

$253.55

-1.17 (-0.46%)

VKTX

Viking Therapeutics

$10.40

-0.18 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 27

    Sep

  • 01

    Oct

  • 06

    Nov

Over a week ago
LGND

Ligand

$256.42

1.38 (0.54%)

08:10
09/11/18
09/11
08:10
09/11/18
08:10
Recommendations
Ligand analyst commentary at Argus »

Ligand price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 06

    Nov

LGND

Ligand

$260.86

3.53 (1.37%)

13:27
08/31/18
08/31
13:27
08/31/18
13:27
Hot Stocks
Ligand CEO sells over $900,000 worth of shares »

Ligand Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

Over a month ago
DARE

Dare Bioscience

$1.01

0.01 (1.00%)

, WSC

WillScot

$16.10

0.2 (1.26%)

10:18
08/17/18
08/17
10:18
08/17/18
10:18
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

DARE

Dare Bioscience

$1.01

0.01 (1.00%)

WSC

WillScot

$16.10

0.2 (1.26%)

LGND

Ligand

$237.18

-2.66 (-1.11%)

COT

Cott Corp.

$15.98

0.34 (2.17%)

AZRE

Azure Power

$15.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

LGND

Ligand

$239.84

-7.88 (-3.18%)

06:25
08/17/18
08/17
06:25
08/17/18
06:25
Initiation
Ligand initiated at Goldman Sachs »

Ligand initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

LGND

Ligand

$240.26

1.99 (0.84%)

09:05
08/10/18
08/10
09:05
08/10/18
09:05
Recommendations
Ligand analyst commentary at H.C. Wainwright »

Ligand price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

LGND

Ligand

$238.27

-8.695 (-3.52%)

08:29
08/09/18
08/09
08:29
08/09/18
08:29
Hot Stocks
Ligand makes offer to buy Vernalis for approximately $43M in cash »

Ligand Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

LGND

Ligand

$246.97

20.635 (9.12%)

08:04
08/08/18
08/08
08:04
08/08/18
08:04
Downgrade
Ligand rating change  »

Ligand downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.